ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with nalorphine in 2 studies
| Studies (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Trials (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Recent Studies (post-2010) (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Studies (nalorphine) | Trials (nalorphine) | Recent Studies (post-2010) (nalorphine) |
|---|---|---|---|---|---|
| 24 | 5 | 0 | 1,134 | 41 | 6 |
| Protein | Taxonomy | ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination (IC50) | nalorphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RATTENBORG, C; SONNE, LM | 1 |
| SONNE, LM | 1 |
2 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and nalorphine
| Article | Year |
|---|---|
[Continuous ventilation and respiration recording demonstrated in a case of ketogan poisoning treated with nalorphine].
Topics: Allylamine; Drug Combinations; Humans; Ketones; Meperidine; Nalorphine; Respiration | 1954 |
[Nalorphine therapy of ketogan poisoning].
Topics: Allylamine; Drug Combinations; Humans; Ketones; Meperidine; Nalorphine; Respiration | 1954 |